Literature DB >> 16977471

Case report: Corticosteroid-resistant nephrotic syndrome: treatment with rapamune.

Liern Jose Miguel, Graciela V Vallejo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16977471     DOI： 10.1007/s00467-006-0302-4

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN： 0931-041X            Impact factor:   3.714


× No keyword cloud information.
  6 in total

Review 1.  Rapamune (RAPA, rapamycin, sirolimus): mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression.

Authors:  S N Sehgal
Journal:  Clin Biochem       Date:  1998-07       Impact factor: 3.281

Review 2.  Rapamycin: a novel immunosuppressive macrolide.

Authors:  S N Sehgal; K Molnar-Kimber; T D Ocain; B M Weichman
Journal:  Med Res Rev       Date:  1994-01       Impact factor: 12.944

Review 3.  Proteinuria and progression in human glomerular diseases.

Authors:  J S Cameron
Journal:  Am J Nephrol       Date:  1990       Impact factor: 3.754

Review 4.  Sirolimus, a new, potent immunosuppressive agent.

Authors:  P A Kelly; S A Gruber; F Behbod; B D Kahan
Journal:  Pharmacotherapy       Date:  1997 Nov-Dec       Impact factor: 4.705

5.  Renal pathology and proteinuria determine progression in untreated mild/moderate chronic renal failure.

Authors:  P S Williams; G Fass; J M Bone
Journal:  Q J Med       Date:  1988-04

Review 6.  Treatment of idiopathic nephrosis by immunophillin modulation.

Authors:  Alain Meyrier
Journal:  Nephrol Dial Transplant       Date:  2003-08       Impact factor: 5.992
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.